Alamar Biosciences launches national blood biomarker initiative for Alzheimer’s research
ALMR•Study scope and assay panel
The project targets about 21,000 plasma samples from 10,000 ADRC participants using the NULISAseq Neuro 220 panel, with an added eMTBR-Tau assay.
National proteomics initiative
Alamar Biosciences launched a national proteomics initiative with leading universities to advance blood-based biomarkers for Alzheimer’s and related dementias.
Public dataset and clinical linkage
The dataset will be made public and linked to NACC IDs, enabling integration with longitudinal clinical data for AI-driven discovery.
